Effect of electrochemical topology on detection sensitivity in MEA assay for drug-induced cardiotoxicity screening

Team members Yiguang Zhu and Dr. Paul Locke were co-authors on a recent article about the use of electrochemical topology to better optimize multielectrode array (MEA) performance for drug testing.

Read the article here

Previous
Previous

From Deference to Deliberation

Next
Next

How Should the 3 R’s Be Revised and Why?